NEW YORK (GenomeWeb) – Dermatology diagnostics firm Mindera today announced the close of its $1 million seed financing round.

The firm said in a statement that Scientific Health Development was among the investors in the oversubscribed round. Proceeds will go towards further validating Mindera's proprietary micro-needle technology and preparing for the launch of its first research products.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.